Jennifer Jarrett Syndax Pharmaceuticals Inc (SNDX) insider trading activity

Jennifer Jarrett is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 90,000 shares of SNDX, which is worth approximately $1.41 Million. The most recent transaction as insider was on Feb 05, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90K

38.46% 3M change

38.46% 12M change

Total Value Held $1.41 Million

Jennifer Jarrett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2025	BUY Grant, award, or other acquisition	-	25,000 Added 21.74%	90,000 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	17,000 Added 20.73%	65,000 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	16,000 Added 25.0%	48,000 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	16,000 Added 33.33%	32,000 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	16,000 Added 50.0%	16,000 Common Stock

Also insider at

RCUS

Arcus Biosciences, Inc. Healthcare

Chief Operating Officer

ARNA

ARENA PHARMACEUTICALS INC Healthcare

Director

SRZN

Surrozen, Inc. Healthcare

RDUS

Radius Health, Inc. Healthcare

Director

JATT-WT

JATT Acquisition Corp

SGMT

Sagimet Biosciences Inc.

Director